References
- Sharma P, Wagner K, Wolchok JD, Allison JP. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer 2011; 11:805 - 12; http://dx.doi.org/10.1038/nrc3153; PMID: 22020206
- Hivroz C, Chemin K, Tourret M, Bohineust A. Crosstalk between T lymphocytes and dendritic cells. Crit Rev Immunol 2012; 32:139 - 55; http://dx.doi.org/10.1615/CritRevImmunol.v32.i2.30; PMID: 23216612
- Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, et al. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood 2012; 119:3073 - 83; http://dx.doi.org/10.1182/blood-2011-07-369736; PMID: 22251483
- Soudja SM, Ruiz AL, Marie JC, Lauvau G. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 2012; 37:549 - 62; http://dx.doi.org/10.1016/j.immuni.2012.05.029; PMID: 22940097
- Chu T, Tyznik AJ, Roepke S, Berkley AM, Woodward-Davis A, Pattacini L, Bevan MJ, Zehn D, Prlic M. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep 2013; 3:701 - 8; http://dx.doi.org/10.1016/j.celrep.2013.02.020; PMID: 23523350
- Tietze JK, Sckisel GD, Zamora AE, Hsiao HH, Priest SO, Wilkins DE, Lanier LL, Blazar BR, Baumgarth N, Murphy WJ. Influenza infection results in local expansion of memory CD8(+) T cells with antigen-nonspecific phenotype and function. [Epub ahead of print] Clin Exp Immunol 2013; Forthcoming http://dx.doi.org/10.1111/cei.12186; PMID: 23937663
- Xu W, Jones M, Liu B, Zhu X, Johnson CB, Edwards AC, Kong L, Jeng EK, Han K, Marcus WD, et al. Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma. Cancer Res 2013; 73:3075 - 86; http://dx.doi.org/10.1158/0008-5472.CAN-12-2357; PMID: 23644531
- Zhu X, Marcus WD, Xu W, Lee HI, Han K, Egan JO, Yovandich JL, Rhode PR, Wong HC. Novel human interleukin-15 agonists. J Immunol 2009; 183:3598 - 607; http://dx.doi.org/10.4049/jimmunol.0901244; PMID: 19710453
- Han KP, Zhu X, Liu B, Jeng E, Kong L, Yovandich JL, Vyas VV, Marcus WD, Chavaillaz PA, Romero CA, et al. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Cytokine 2011; 56:804 - 10; http://dx.doi.org/10.1016/j.cyto.2011.09.028; PMID: 22019703
- Murphy WJ, Welniak L, Back T, Hixon J, Subleski J, Seki N, Wigginton JM, Wilson SE, Blazar BR, Malyguine AM, et al. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses. J Immunol 2003; 170:2727 - 33; PMID: 12594303